Cargando…
Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer
Breast cancer (BC) is the most common malignancy, and the largest cause of cancer death among women. The interactions between tumor cells and tumor micro environmental factors have a major impact on tumor progression. One of the critical pro-inflammatory cytokines present in breast cancer tumor micr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641119/ https://www.ncbi.nlm.nih.gov/pubmed/37964831 http://dx.doi.org/10.1016/j.heliyon.2023.e21060 |
_version_ | 1785146704665772032 |
---|---|
author | Abdolvand, Maryam Shahini Shams Abadi, Milad Soltani, Amin Banisharif, Fatemeh Ghatrehsamani, Mahdi |
author_facet | Abdolvand, Maryam Shahini Shams Abadi, Milad Soltani, Amin Banisharif, Fatemeh Ghatrehsamani, Mahdi |
author_sort | Abdolvand, Maryam |
collection | PubMed |
description | Breast cancer (BC) is the most common malignancy, and the largest cause of cancer death among women. The interactions between tumor cells and tumor micro environmental factors have a major impact on tumor progression. One of the critical pro-inflammatory cytokines present in breast cancer tumor microenvironment is TNF-α. The aim of this study was to evaluate the long-term effect of TNF-α (1 week) along with p38 or TAK1 inhibitors as well as metformin on induction of cellular death, cancer stem cell and expression of metastatic marker CXCR4. MCF-7 and MDA-MB-231 cells were treated with TNF-α for one week and then were treated with combination of Takinib, SB203580 or Metformin; after all treatments were done, cell proliferation, cellular death, surface expression of CXCR4, CD44 and CD24 were determined. The results showed that treatment with TNF-α alone or in combination with Takinib, SB203580 and metformin elevated induction of cellular death in both cell lines compared to the control group. TNF-α also increased CXCR4 expression in MCF-7 cells, but it reduced its expression in the MDA-MB-231 cells. Also, breast cancer stem cells (BCSCs) population decreased in MDA-MB-231 cells treated with TNF-α alone or in combination with SB203580 and metformin. Although, in MCF-7 cells only combination of TNF-α and Takinib reduced BCSCs population in a time dependent manner. Altogether, we showed that TNF-α alone or in combination with other treatments can affect the progression of breast cancer. |
format | Online Article Text |
id | pubmed-10641119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-106411192023-11-14 Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer Abdolvand, Maryam Shahini Shams Abadi, Milad Soltani, Amin Banisharif, Fatemeh Ghatrehsamani, Mahdi Heliyon Research Article Breast cancer (BC) is the most common malignancy, and the largest cause of cancer death among women. The interactions between tumor cells and tumor micro environmental factors have a major impact on tumor progression. One of the critical pro-inflammatory cytokines present in breast cancer tumor microenvironment is TNF-α. The aim of this study was to evaluate the long-term effect of TNF-α (1 week) along with p38 or TAK1 inhibitors as well as metformin on induction of cellular death, cancer stem cell and expression of metastatic marker CXCR4. MCF-7 and MDA-MB-231 cells were treated with TNF-α for one week and then were treated with combination of Takinib, SB203580 or Metformin; after all treatments were done, cell proliferation, cellular death, surface expression of CXCR4, CD44 and CD24 were determined. The results showed that treatment with TNF-α alone or in combination with Takinib, SB203580 and metformin elevated induction of cellular death in both cell lines compared to the control group. TNF-α also increased CXCR4 expression in MCF-7 cells, but it reduced its expression in the MDA-MB-231 cells. Also, breast cancer stem cells (BCSCs) population decreased in MDA-MB-231 cells treated with TNF-α alone or in combination with SB203580 and metformin. Although, in MCF-7 cells only combination of TNF-α and Takinib reduced BCSCs population in a time dependent manner. Altogether, we showed that TNF-α alone or in combination with other treatments can affect the progression of breast cancer. Elsevier 2023-10-16 /pmc/articles/PMC10641119/ /pubmed/37964831 http://dx.doi.org/10.1016/j.heliyon.2023.e21060 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Abdolvand, Maryam Shahini Shams Abadi, Milad Soltani, Amin Banisharif, Fatemeh Ghatrehsamani, Mahdi Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer |
title | Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer |
title_full | Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer |
title_fullStr | Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer |
title_full_unstemmed | Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer |
title_short | Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer |
title_sort | chronic treatment with tnf-α, alone and in combination with takinib, sb203580 and metformin induce cell death in breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641119/ https://www.ncbi.nlm.nih.gov/pubmed/37964831 http://dx.doi.org/10.1016/j.heliyon.2023.e21060 |
work_keys_str_mv | AT abdolvandmaryam chronictreatmentwithtnfaaloneandincombinationwithtakinibsb203580andmetformininducecelldeathinbreastcancer AT shahinishamsabadimilad chronictreatmentwithtnfaaloneandincombinationwithtakinibsb203580andmetformininducecelldeathinbreastcancer AT soltaniamin chronictreatmentwithtnfaaloneandincombinationwithtakinibsb203580andmetformininducecelldeathinbreastcancer AT banishariffatemeh chronictreatmentwithtnfaaloneandincombinationwithtakinibsb203580andmetformininducecelldeathinbreastcancer AT ghatrehsamanimahdi chronictreatmentwithtnfaaloneandincombinationwithtakinibsb203580andmetformininducecelldeathinbreastcancer |